Sarfez Pharmaceuticals
OrganisationROR
Trials
Phase 3, Completed, 24 people, 2 Jul 2025
Phase 3, Completed, 24 people, 11 Jun 2025
Phase 1, Terminated, 20 people, 26 Apr 2018
Named in competing interests
Consulting or advice, Fees or honoraria, 2 Sept 2026
Sources: pubmed.ncbi.nlm.nih.gov